Gene Symbol | MAP3K13 |
---|---|
Entrez Gene | 9175 |
Alt Symbol | LZK, MEKK13, MLK |
Species | Human |
Gene Type | protein-coding |
Description | mitogen-activated protein kinase kinase kinase 13 |
Other Description | leucine zipper-bearing kinase|mixed lineage kinase |
Swissprots | Q15450 Q05BY6 B4DLE3 O43283 B4DMV2 D3DNU1 B4DZJ4 B2R6U2 Q2NKN3 |
Accessions | EAW78224 EAW78225 O43283 AB001872 BAA24817 AI690808 AK123148 AK296961 BAG59505 AK297646 BAG60014 AK302951 BAG64106 AK312714 BAG35589 BC015996 BC026249 BC031677 AAH31677 BC036593 BC111726 AAI11727 BQ432918 Z25428 CAA80915 XM_011513310 XP_011511612 NM_001242314 NP_001229243 NM_001242317 NP_001229246 NR_038322 NM_004721 NP_004712 |
Function | Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. {ECO:0000269|PubMed:11726277, ECO:0000269|PubMed:12492477, ECO:0000269|PubMed:9353328}. |
Subcellular Location | Cytoplasm {ECO:0000269|PubMed:9353328}. Membrane {ECO:0000269|PubMed:9353328}; Peripheral membrane protein {ECO:0000269|PubMed:9353328}. |
Tissue Specificity | Expressed in the adult brain, liver, placenta and pancreas, with expression strongest in the pancreas. {ECO:0000269|PubMed:9353328}. |
Top Pathways | MAPK signaling pathway |
Human MAP3K13 full length protein - ab160368 from Abcam
|
||||||||||
Human MAP3K13 protein fragment - ab160369 from Abcam
|
||||||||||
Recombinant Human MAP3K13 Protein - H00009175-P01 from Novus Biologicals
|
||||||||||
MAP3K13 Partial Recombinant Protein - H00009175-Q01 from Novus Biologicals
|
||||||||||
MAP3K13 peptide - orb218229 from Biorbyt
|
||||||||||
LZK Blocking Peptide - abx063560 from Abbexa
|
||||||||||
MAP3K13 - H00009175-P01-10 from Acris Antibodies
|
||||||||||
MAP3K13 - H00009175-P01-25 from Acris Antibodies
|
||||||||||
MAP3K13 - H00009175-Q01-10 from Acris Antibodies
|
||||||||||
MAP3K13 - H00009175-Q01-25 from Acris Antibodies
|
||||||||||
MAP3K13 - P5582 from Acris Antibodies
|
||||||||||
LZK Blocking Peptide - CBP2366 from Cohesion Biosciences
|
||||||||||
LZK (F183) Peptide - BS1874P from Bioworld Technology
|
||||||||||
Recombinant Human Mitogen-activated protein kinase kinase kinase 13(MAP3K13) ,partial - CSB-YP013421HU CSB-EP013421HU CSB-BP013421HU CSB-MP013421HU from Cusabio
|
||||||||||
MAP3K13 Recombinant Protein Antigen - NBP1-81274PEP from Novus Biologicals
|
||||||||||
MAP3K13 Recombinant Protein Antigen - NBP1-81273PEP from Novus Biologicals
|
||||||||||
MAP3K13 Recombinant Protein Antigen - NBP1-81272PEP from Novus Biologicals
|
||||||||||
MAP3K13-LZK-Antibody-C-term-Blocking-peptide - BP8008a from Abgent, a WuXi AppTec company
|
||||||||||
MAP3K13-LZK-Blocking-Peptide-C-term-S869 - BP8008d from Abgent, a WuXi AppTec company
|
||||||||||
MAP3K13 Peptide, Human - M34GP09169H from Creative Peptides
|
||||||||||
MAP3K13 fusion protein - Ag26907 from Proteintech Group
|
||||||||||
Mitogen-activated protein kinase kinase kinase 13 (MAP3K13), partial, Recombinant Protein - MBS1153016 from MyBioSource
|